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Abstract
Although many reviews exist characterizing the molecular differences of GABAB receptor 
isoforms, there is no current review of the in vivo effects of these isoforms. The current review 
focuses on whether the GABAB1a and GABAB1b isoforms contribute differentially to behaviors in 
isoform knockout mice. The roles of these receptors have primarily been characterized in 
cognitive, anxiety, and depressive phenotypes. Currently, the field supports a role of GABAB1a in 
memory maintenance and protection against an anhedonic phenotype, whereas GABAB1b appears 
to be involved in memory formation and a susceptibility to developing an anhedonic phenotype. 
Although GABAB receptors have been strongly implicated in drug abuse phenotypes, no isoform-
specific work has been done in this field. Future directions include developing site-specific 
isoform knockdown to identify the role of different brain regions in behavior, as well as 
identifying how these isoforms are involved in development of behavioral phenotypes.
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1. Introduction
The current literature review focuses on pre-clinical behavioral studies examining the 
differing roles between GABAB1a and GABAB1b receptors, which tend to be pre- and 
postsynaptic, respectively. This review addresses a critical gap in the current literature: 
whether in vivo studies have identified specific roles of GABAB1a and GABAB1b receptors 
in behavior. To date, multiple reviews have been published concerning the molecular 
differences between these receptors. Each of these reviews has called on the necessity of in 
vivo research to demonstrate behavioral differences attributed to the different receptors. In 
vivo studies using animal models have now been published, although there is no current 
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literature linking the isoforms to behavior in humans. The current literature review 
synthesizes and critically analyzes the literature to-date, as well as elucidates gaps in the 
research and proposes future areas of study. We hypothesize that a review of this area will 
elucidate separate roles of GABAB1a and GABAB1b receptors.
2. Characterization of the GABAB receptor
2.1 General information
As the metabotropic component of the brain’s major inhibitory system, GABAB receptors 
(GABABRs) have been implicated in a wide range of human behaviors. These include 
development, substance abuse, and behavioral pathologies such as anxiety and depression 
(Agabio et al., 2012; Benke, 2013; Bowery, 2006; Kumar et al., 2013). GABABRs fall into 
the class III metabotropic receptor category, along with metabotropic glutamatergic 
receptors (mGluR), calcium sensing receptors, and some pheromone and taste receptors. 
Class III receptors have a dynamic bilobate structure, where each subunit has a clamshell-
like shape. When a ligand binds to a subunit, the clamshell “closes,” causing the receptor to 
activate (Pin et al., 2003). The GABABR is a relatively consistent heterodimer. A functional 
receptor is comprised of a GABAB1 (B1) and GABAB2 (B2) subunit (Pin et al., 2004). 
Variation of the heterodimer is relegated to the B1 subunit. While multiple isoforms of B1 
have been identified, the primary isoforms that are part of the central nervous system and are 
conserved across many species, including humans, rodents, and even cockroaches, are the 
B1a and B1b subunits (Blankenburg et al., 2015; Lee et al., 2010; Kaupmann et al., 1998; 
Pinard et al., 2010). Expression of a receptor into B1a or B1b is regulated by unique cAMP-
induced binding in specific promoter regions, including interactions between cAMP 
response element-binding protein (CREB), activating transcription factor 4 (ATF4), and 
upstream stimulatory factors (USF). CREB acts as a promotor for both B1a and B1b, 
whereas overexpression of ATF stimulates B1a promotor activity but inhibits B1b promotor 
activity. In the absence of CREB binding, USF inhibits expression of B1b (Steiger et al., 
2004).
First discovered in 1998 by Hawrot et al. (1998), the pair of sushi domains on the end of the 
N-terminal ectodomain that distinguishes the B1a subunit from the B1b subunit was 
structurally analyzed by Blein et al. (2004). Also known as a complement control protein, 
the presence of the sushi domain is believed to be responsible for the increased stability of 
B1a/B2 heterodimers as compared to B1b/B2 heterodimers. Further, inserting the B1a sushi 
domain into mGluR2, another Class III metabotropic receptor that has no endogenous sushi 
domain, increases surface stability (Hannan et al., 2012). As part of the complement control 
proteins, the sushi domains on B1a have long been proposed to be involved in protein-
protein interactions that regulate the system (Marshall et al., 1999). The sushi domain of B1a 
has been shown to interact with the matrix protein fibrillin-2, an important scaffolding 
protein, whereas B1b does not (Blein et al., 2004). This interaction with auxiliary proteins 
may lead to differences in receptor activity, pharmacology, and localization of receptors 
which cannot be completely modeled in in vitro studies (Marshall et al., 1999; Mohler & 
Fritschy, 1999). Further, Hawrot et al. (1998) suggest that the extracellular location of the 
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sushi domains may indicate that they are important for regulating ligand binding other than 
GABA, although data supporting this theory have not yet been published.
2.2 Receptor location
The B1 isoforms are found widely across the brain and are located in most neurons, but not 
in non-neuronal cells, such as glial cells (Bischoff et al., 1999; Benke et al., 1999; Fritschy 
et al., 1999; Liang et al., 2000). It has been repeatedly demonstrated that B1a/B2 and 
B1b/B2 receptors localize on different areas of the neuron. Generally, B1a is located 
presynaptically on axonal terminals, while B1b is located postsynaptically on dendritic 
spines. However, both isoforms are present as autoreceptors and B1a receptors are also 
found on the dendritic branches (Bischoff et al., 1999; Kornau, 2006; Pinard et al., 2010; 
Waldmeier et al., 2008). Human B1a and B1b isoforms appear to follow this same pattern. 
Mammalian cells transfected with human B1a and B1b show cerebellar expression on 
granule and Purkinje cells, respectively (Kaupmann et al., 1998). Biermann et al. (2010) 
demonstrated that differential localization of the receptor isoforms is dependent upon the 
presence and amino acid sequence of the sushi domain. B1a receptors track to axonal 
locations, but when the amino acid sequence of the sushi domain is changed or deleted, 
axonal location is abolished. Further, inserting the sushi domain on B1b or mGluR1a, which 
respectively tend to have dendritic or somatodendritic locations, also causes them to move to 
axons. One notable exception to the pre- and postsynaptic classification of B1a and B1b 
isoforms is the medial habenula, wherein B1b receptors appear to be presynaptically located 
on afferents to the interpeduncular nucleus (Bischoff et al., 1999). Exceptions such as the 
medial habenula highlight the importance of discerning between the roles of pre- versus 
postsynaptic and B1a versus B1b receptors and refraining from using such terms 
interchangeably.
Although both isoforms are prevalent across the central nervous system, the ratio of B1a to 
B1b varies based on cell type and anatomical structure. Many brain areas express similar 
levels of B1a and B1b mRNA, including the amygdaloid nuclei and substructures of the 
hippocampus. However, GABAergic cerebellar Purkinje cells express much higher mRNA 
levels of B1b than of B1a, whereas glutamatergic granular cells of the cerebellum display 
higher levels of B1a and negligible levels of B1b mRNA (Bischoff et al., 1999; Liang et al., 
2000). This is not surprising, as B1a receptors tend to be presynaptically colocalized with 
mGluR2s (Kornau, 2006; Pinard et al., 2010; Ulrich & Bettler, 2007), and granular cells are 
the major excitatory input of the hippocampus and cerebellum. Conversely, Purkinje 
neurons are GABAergic and receive input from glutamatergic parallel fibers that originate in 
granular cells. Other anatomical areas of discrepancy include higher levels of B1a mRNA in 
the lateral nuclei of the amygdala, ventromedial hypothalamic nuclei, and all areas of the 
midbrain, including the ventral tegmental area (VTA). Higher B1b mRNA levels are notably 
expressed in the nucleus accumbens, ventral pallidum, and most areas of the thalamus 
(Bischoff et al., 1999). Although protein levels of B1a and B1b have not yet been 
investigated in such specific brain regions, Benke et al. (1999) investigated crude membrane 
protein levels of B1a and B1b in general brain regions. They found that whereas B1a and 
B1b protein expression is similar in the hippocampus, B1a shows greater expression in the 
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olfactory bulb and striatum, and B1b shows greater expression in the cerebral cortex, 
thalamus, cerebellum, and medulla.
2.3 In vitro receptor roles
At the cellular level, activation of pre- and postsynaptic GABABRs leads to differing 
downstream effects. Kornau (2006) summarizes these effects as the following: 
presynaptically, receptors inhibit neurotransmitter release by inhibiting Ca++ channels via 
the β/γ subunits of the G protein. An emerging role of inhibited exocytosis following 
calcineurin release in response to increased cytoplasmic calcium levels has also been 
identified (McClure-Begley et al., 2014). Secondarily, at glutamatergic terminals, 
presynaptic receptors may retard synaptic vesicle recruitment following sustained activity of 
the system via the adenylate cyclase cascade activated by the i/oα subunit of the G protein. 
Postsynaptically, the β/γ subunits activate potassium class 3 (Kir3) channels, causing slow 
inhibitory postsynaptic currents (IPSC) and inducing long term potentiation at glutamatergic 
sites (Kornau, 2006).
Some of these effects have been directly linked to B1a or B1b receptor isoforms. Vigot et al. 
(2006) demonstrated that hippocampal B1b is involved in Kir3 channel modulated 
postsynaptic inhibition. Conversely, B1a located on dendritic branches inhibits cortical 
neurons via Ca++ channels, independent of the typical postsynaptic Kir3 channel mechanism 
(Perez-Garci et al., 2006). B1b also modulates postsynaptic inhibition of CA1 hippocampal 
cells in B1b knockout mice. B1b knockout, but not wild type or B1a knock out mice, show 
reduced baclofen-induced Kir3 currents (Vigot et al. 2006). B1a receptors control glutamate 
release in fibers projecting from the cortex to the thalamus (Ulrich & Bettler, 2007), and are 
mostly localized on glutamatergic terminals in the hippocampus (Shaban et al., 2006; Vigot 
et al., 2006). Further, B1a knockout mice show impaired excitatory postsynaptic current 
(EPSC) amplitude reduction following activation of GABAB heteroreceptors, indicating 
impairment in regulating presynaptic inhibition. Both isoforms have been shown to act as 
autoreceptors, as baclofen reduces IPSC amplitude in both isoform knockouts to a similar 
extent (Vigot et al., 2006). On a larger systems level, Hannan et al. (2012) suggest that the 
stability of the B1a receptor at presynaptic locations may act as an inhibitory brake, reducing 
excessive releases of glutamate. B1a receptors have been shown to gate glutamatergic inputs 
to excitatory neurons of the amygdala (Pan et al., 2009), and that presynaptic receptor 
activation from cortical afferents is important for LTP induction in lateral amygdala 
principal neurons (Lange et al., 2014). The audiocortex to basolateral amygdala (BLA) 
pathway is also modulated by presynaptic GABABRs (Cho et al., 2013). Conversely, the 
relative instability of the B1b receptor at postsynaptic locations may contribute to NMDA-
mediated postsynaptic plasticity and in very severe conditions may lead to neurotoxicity.
It is greatly important to note that the roles of each receptor isoform are not constant, even 
within specific parameters. The roles of B1a and B1b may change based on structural 
location of the receptor, such as B1b modulating postsynaptic depression in the 
hippocampus, but B1a modulating postsynaptic depression in cortical neurons via different 
mechanisms (Perez-Garci et al., 2006; Vigot et al., 2006). Receptor roles, with and without 
discrimination between isoforms, have been shown to change even at the cellular level 
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during pharmacological manipulation (Cruz et al., 2004; Labouebe et al., 2007; Michaeli & 
Yaka, 2010). These considerations reinforce the need for a site-specific method of isoform 
knockdown to investigate how the roles of B1a and B1b change across different brain 
structures (see section 3.3).
3. Identifying and modeling GABAB receptor isoforms
3.1 Indirect and non-causal isoform classification
As discussed in section 1.2, B1a/B2 receptors tend to locate presynaptically, whereas 
B1b/B2 receptors tend to locate postsynaptically. Therefore, some studies may infer whether 
a receptor is B1a or B1b by its electrophysiological properties. One commonly used 
technique is whole-cell patch clamp electrophysiology, which allows for stable intracellular 
recording to study the activity of ion channels within the membrane of pre- and postsynaptic 
cells. Vigot et al. (2006) used whole-cell patch clamp to demonstrate that B1a knockout 
mice hippocampal cells show robustly impaired inhibition of EPSC amplitude in the 
presence of baclofen, whereas B1b knockout mice hippocampal cells show a 60% reduction 
in outward current of IPSCs mediated by activating Kir3 channels. These results were 
specific to application of baclofen, suggesting that they are specific to GABABRs. When not 
using isoform knockout mice, involvement of GABABR subunits can be extrapolated as B1a 
when impaired EPSC amplitude is present, or as B1b when alterations in Kir3-mediated 
IPSCs are seen (see section 3.2). Changes in pre- and postsynaptic architecture can also be 
looked at using techniques such as electron microscopy and immunogold labelling to 
observe changes in cellular structure. Increases in excitatory synapses or dendritic spines 
may imply a role for B1a or B1b receptors, respectively, as the isoforms are distributed in 
such a manner across the cell (Terunuma et al., 2014; Vigot et al., 2006). Alterations in B1a 
and B1b may also be identified in a direct, but non-causal manner via in situ hybridization. 
Site-specific labelled DNA or RNA tissue can be quantified and correlated with behavior or 
drug treatment (McCarson et al., 2006, 2005; Sands et al. 2004, 2003).
3.2 Direct genetic manipulation
As described in Vigot et al. (2006), the knockout mice were created via multiple intricate 
steps. BALB/C embryonic stem cells were made more permeable using an electrical field 
(electroporation), allowing introduction of constructs with mutated codons. The mutated 
codons selectively prevented the translation of B1a or B1b proteins by changing the 
initiation codons into stop codons. The BALB/C stem cells were then injected into C57BL/6 
(B6) blastocysts to create a founder population. To ensure a BALB/C background for the 
mutant mice, the founder mice were crossed with BALB/C mice that expressed targeted 
Cre-recombinase, allowing site-specific recombination for the targeted B1a and B1b genes 
of interest. The knockout mice were reported to show no overt abnormalities in phenotype 
compared to the wild type mice. However, how the mice were phenotyped was not reported. 
mRNA levels for B1a and B1b were normal in both groups of mice, but B1a and B1b did 
not translate mRNA into B1a or B1b protein, respectively. This loss of translation confirmed 
that the change of the transcription initiation codon into a stop codon worked. Some 
apparent compensation occurred, as B1a knockouts showed an increase in B1b protein, and 
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B1b knockouts showed an increase in B1a protein (129% and 115% of wild-type, 
respectively).
3.3 Considerations of identifying and modeling receptor forms
Currently, the only “direct” way of implicating B1a or B1b isoform subunits in behavior is 
by using isoform knockout mice. Other indirect, or correlational, methods exist, including 
electrophysiological recordings and in situ hybridization. Methods of directly and indirectly 
targeting the GABAB isoforms have both pros and cons. For indirect methods, the primary 
concern is that changes to the system are looked at secondary to behavior, making the 
isoform data correlative to the behavior. However, this also offers strength over the 
knockout methodology. Looking at the system secondary to behavior removes compensatory 
mechanisms and alterations in development that may be present in knockout models. 
Contrary to in situ hybridization, electrophysiological, electron microscopy, and 
immunogold labelling methods do not directly identify the isoform. Whether it is B1a or 
B1b has to be inferred by identifying whether the receptor is located at the axon terminal or 
on the dendritic spine.
Use of genetic knockouts offers the ability to infer causation of behavioral changes via 
alterations in the GABABR isoforms. Further, the cellular characteristics of these models 
have been well characterized and support the use of indirect models to identify the isoforms 
involved in behavior (Shaban et al., 2006; Vigot et al., 2006). As described in section 2.2, 
these models are not conditional knockouts, and the different isoforms are known to be 
involved in development. Fritschy et al. (1999) demonstrated that, relative to B1b protein 
expression levels in the adult brain, Sprague Dawley rats show double the amount of B1a 
from post-natal days (PND) 0–10. Expression levels then drop to around 50% of B1b levels 
at PND 21 and adulthood. Conversely, B1b remains at 50% of its adult levels at PND 0 and 
5 then peaks at 150% at PND 10 and 21 before normalizing in adulthood. However, mRNA 
levels of B1a have been shown to be higher in adult brain (Bischoff et al., 1999; Liang et al., 
2000). These levels suggest that B1a plays an important role in development before 
weanling age, whereas B1b becomes the predominant isoform at and after the time of 
weaning. The higher B1a mRNA levels during adulthood may indicate that, following 
weaning, B1a becomes important for interactions with other proteins that may further the 
development of the brain.
Behaviorally, the presence of B1a during development plays a role in stress resilience 
(O’Leary et al., 2014). Although Vigot et al. (2006) report no aberrant behavior between the 
knockouts and the wild types, the types of behaviors monitored were not reported and this 
does not negate the possibility of developmental alterations, specifically system 
compensation for global knockout of each isoform. As previously mentioned, global 
knockout of the B1a and B1b isoforms resulted in upregulation of respective B1b and B1a 
protein levels compared to the wild type. However, Vigot et al. (2006) suggest a lack of 
compensation by the GABAB system, as baclofen binding is at half maximal levels in each 
of the knockouts compared to the wild type. This does not rule out compensation by other 
systems, specifically mGluRs which are often colocalized with B1a receptors (Kornau, 
2006), or the fast-acting GABAA receptor system. Other experiments have demonstrated 
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that direct manipulation outside of the GABABR system directly alters function of 
GABABRs and behavior. For example, knockout of semialdehyde dehydrogenase, which 
blocks downstream breakdown of GABA, causes epileptic seizures (Vardya et al., 2010). 
Replacement of serine 783 for an alanine residue reduces B2 receptor expression and leads 
to reduced contextual fear and impaired memory in the Barnes Maze task (Terunuma et al, 
2014). Finally, knocking out B1 receptors specifically on orexin neurons alters sleep/wake 
patterns (Matsuki et al., 2009). Although these manipulations do not directly interfere with 
isoform expression, the authors suggest that part of the behavioral profile is due to 
alterations in postsynaptic GABABR activity (Matsuki et al., 2009; Terunuma et al., 2014; 
Vardya et al., 2010). Therefore, if alterations in other systems affect the GABABR system, it 
is not inconceivable to think that isoform knockout as described by Vigot et al. (2006) is 
affecting systems outside of the GABABRs.
Age is also an important factor to consider. It is not clear at what age point these analyses 
were done; Vigot et al. (2006) conducted most non-behavioral procedures before adulthood; 
therefore, these results may be different or indicate compensational or developmental 
differences at alternative time points. The developmental role of B1 isoforms also presents a 
problem for electrophysiological methods. Often-times, cell recordings are taken from 
animals that have not yet reached adulthood, including many of the studies reviewed herein. 
As B1 isoform expression changes so rapidly over development, using electrophysiological 
data taken from young animals to support behavioral differences seen in adults may be 
confounded. An alternative direct method of isoform knock down is using a viral method, 
which is conditional and therefore avoids many pitfalls of the knockouts. In contrast to 
global knockouts, this method is brain-region specific which is often of interest in 
behavioral tasks (Cho et al., 2013; Shaban et al., 2006; Vigot et al., 2006).
In short, the genetic knockout isoform model is the most widely used across the studies 
discussed herein. However, this model may suffer from system compensation, loss of 
isoform-specific developmental roles, inability to make site-specific conclusions, and 
application of electrophysiological work done during adolescence to explain behavior in 
adulthood. To fully support the conclusions of the behavioral work in the next few sections, 
other methods of isoform identification must also be employed. These include in situ 
hybridization to understand how basic behavior alters isoform expression, and site-specific 
knockdown to understand the isoform-specific circuitry of these behaviors.
4. Existing in vivo work
4.1 Cognition: Learning and memory
4.1.1 Hippocampus-Based Tasks—Table 1 indicates a long list of cognitive tasks that 
have been employed to identify the role of each isoform in learning and memory. Novel 
object recognition, familiar object recognition, and y-maze spontaneous alterations are 
considered to be hippocampal-based learning tasks. B1a and B1b are evenly distributed 
across the different hippocampal formations (Bischoff et al., 1999), however, B1a and B1b 
are more likely to be located on pyramidal and granular cells, respectively (Liang et al., 
2000). This different cellular distribution may indicate different roles in development of 
memory and learning.
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Novel object recognition tasks introduce an animal to two objects in the training phase, then 
replace one familiar object with a novel object. The expected behavior is for the animal to 
remember the familiar object, and therefore spend more time exploring the novel object. In a 
one-time novel object recognition task, Vigot et al. (2006) demonstrated no effect of 
genotype or time on object discrimination index between time-point 0 (initial object 
presentation) and reintroduction 24 hours later, indicating that isoform knockouts and wild 
type mice approached the object similarly at initial presentation and presentation 24 hours 
later. However, Jacobson et al. (2007a) showed that wild types, but not B1b knockouts, 
investigate the familiar object less 24 hours following initial presentation. In both 
experiments, only B1a knockouts showed no discrimination between a novel and a familiar 
object, and did not show recognition of the familiar object 10 minutes following the first 
presentation (Table 1). Vigot et al. (2006) attribute this loss of discrimination to reduced 
EPSPs and loss of GABAergic-mediated LTP in the hippocampus of B1a knockout mice. 
Again, these electrophysiological recordings were taken from adolescent brain slices, 
although the behavior was measured in adulthood. Electrophysiological recordings in adult 
brains may not demonstrate reduced EPSPs due to system compensation. If such were the 
case, Vigot et al.’s (2006) interpretation would not be supported. Cullen et al. (2014) also 
used an object discrimination task comparing only wild type and B1a knockout mice, but 
included a longer period of training than one 3-minute session. Mice were given three daily 
10-minute sessions with two identical glass beakers during which both genotypes explored 
each object to similar extents. Two and 24 hours following training, mice were given a 3-
minute test session with a novel and familiar object. At two hours, both wild type and B1a 
knockout mice investigated the novel object more, but at 24 hours, the B1a knockouts failed 
to discriminate between the familiar and novel object. Immediately following the novel 
object tests, both familiar training objects were placed in the arena for a 3-minute session, 
but one object was placed in a novel location. Again, at two hours, both genotypes preferred 
the novel location object, but at 24 hours, the B1a knockout mice did not discriminate 
between the familiar and novel object locations. Cullen et al. (2014) suggest that these data 
represent the ability of B1a knockout mice to initially consolidate a memory, but an inability 
to maintain this memory (Table 1). The authors suggest that the primary mechanism of this 
memory decay may be the loss of B1a receptor-mediated inhibition in the hippocampus, 
causing over-excitation of the CA3 region, leading to a decline in memory maintenance 
(Figure 1).
The y-maze task is indicative of spatial working memory by measuring how apt an animal is 
at visiting unfamiliar arms of the maze. Correct alterations are counted when the mouse 
travels to each new arm of the maze in succession without visiting a familiar arm. Both 
knockout groups showed a decreased percentage of correct alterations in the y-maze 
compared to the wild type group, with only the B1b knockouts displaying increased 
locomotion (Jacobson et al., 2007a) (Table 1). Although locomotor activity was not 
quantified by Vigot et al. (2006), the number of initial stretch attend postures (SAPs) 
towards the object at time-point 0 was the same across all genotypes. However, in the 
Jacobson et al. (2007a) study, B1b mice showed higher levels of SAPs towards the objects 
than other genotypes, suggesting an alteration in locomotion during both object recognition 
and the y-maze task. Object recognition does not inherently account for basal locomotion 
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and it may be expected that increased locomotion would cause a general increase in 
exploratory behavior. This could explain the lack of “object recognition” in the B1b mice at 
24 hours when only one object is available to explore if the B1b mice are more active in the 
apparatus. Although B1b knockout mice showed overall increased locomotion, the y-maze is 
less susceptible to differences in basal locomotion because the animal is simply asked to 
choose the correct arm over the course of one trial (Jacobson et al., 2007a).
These results suggest that B1a knockout mice display reductions in recognition of familiar 
and novel objects, whereas both B1a and B1b knockouts display reductions in spatial 
memory. The hippocampus has been implicated in both short-term and long-term object 
recognition. Specifically, the role of NMDA receptors in object memory via LTP is well 
recognized (Warburton et al., 2013). As B1a receptors colocalize with glutamatergic 
receptors and B1a knockouts also show a loss of LTP in the hippocampus (Vigot et al., 
2006), it is reasonable to hypothesize that object memory is dependent upon synchrony of 
glutamatergic- and GABAergic-mediated LTP (Figure 1). Therefore, as demonstrated by the 
current studies, loss of object recognition should be present in B1a, but not B1b, knockout 
mice. Conversely, Jacobson et al. (2007a) suggest that both isoforms are involved in 
hippocampal spatial memory. Spatial memory is comprised of many different elements 
including place, route, item, and temporal organization coding (Eichenbaum & Cohen, 
2014). The y-maze task used by Jacobson et al. (2007a) presents only one task of spatial 
memory, and a simple one at that. More complicated spatial tasks, such as the Barnes maze 
or radial arm maze, may show isoform-specific disruptions in spatial memory that would 
allow for a greater understanding of how each isoform works at a circuitry level in spatial 
memory development. Further, as these studies employed the use of global knockouts, it is 
important to consider that brain regions outside of the hippocampus are involved in these 
results. Site-specificity could be directly investigated in the knockout animals. Other 
receptor systems could be site-specifically antagonized via microinjection prior to the 
behavioral tasks. For example, glutamate antagonists could be microinjected into the CA3 
region of the hippocampus to investigate whether this antagonism reverses the impairments 
in memory retention observed by Cullen et al. (2014) in the B1a knockout mice. Conversely, 
the start codon for each isoform could be site-specifically knocked-in, to see if 
reintroduction of the receptor reversed behavior seen in the isoform knockouts. However, 
the preferred method would be a viral knockdown that is administered in adulthood. This 
method would be informative about the necessity and specificity of specific brain regions in 
behavior while also avoiding long-term developmental considerations of isoform knockout. 
It would also allow for isoform knockdown in multiple breeds, allowing for site-specificity 
to be investigated in lines which the behavior of interest is well characterized in or 
selectively bred for.
4.1.2 Amygdala-based tasks—In contrast to object and spatial memory, amygdala-
dependent tasks, which require overt pairing of an aversive stimulus with an appetitive 
substance or cue, showed impairments in both knockout genotypes, whereas context 
learning is unaffected. Such tasks include conditioned taste aversion (CTA) where an 
appetitive substance, such as saccharin, is devalued through behavioral measures, such as 
pairing saccharin access with a shock, or via appetitive measures, such as pairing it with 
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lithium chloride to induce sickness (LiCl). Following devaluation, the reinforcing substance 
can be given in a period of extinction, where the aversive stimulus is not present, to measure 
how long the animal avoids the once appetitive reinforcer. Jacobson et al. (2006a) showed 
that, following one pairing with LiCl, B1a animals failed to acquire a CTA to saccharin 
solution, although 100% of the B1a animals showed sickness following the LiCl 
administration. BALB/C wild type animals showed extinction of CTA behavior on the 5th 
day of extinction testing. However, B1b knockouts remained at an aversion index of around 
80% for the remainder of saccharin testing. Aversion persisted during a retest that took place 
a week after the end of extinction testing. A perseveration test was performed a week after 
the retest. The B1b animals continued to avoid the saccharin solution during the 
perseveration test, indicating that it was the association between the sickness and the taste, 
not the sickness and bottle location, which was persisting. CTA extinction was tested out to 
4 weeks after the initial saccharin and LiCl pairing, at which point B1b animals still failed to 
extinguish saccharin aversion (Table 1). All tests were run in genotypes that were not given 
LiCl, and there were no specific genotypic effects on saccharin consumption. At all tests, 
total fluid consumption was comprised of about 80% saccharin intake. The CTA task 
employed by Jacobson et al. (2006a) represents an unconventional form of extinction for 
two reasons. The LiCl injection and extinction testing took place in the same context as the 
initial preference testing. CTA extinction testing assesses an animal’s ability to increase 
responding to reacquire a previous behavior, whereas most extinction paradigms assess 
whether an animal begins to inhibit responding. Initial learning and extinction learning are 
also thought to be dependent on different processes. It has been shown that the central 
nucleus of the amygdala is involved in learning the reinforcer-sickness association, but that 
the BLA is necessary for extinguishing CTA as well as fear associations (Bahar et al., 2004). 
This may suggest that B1a and B1b containing receptors are differentially controlling 
processes of CTA. Although the basolateral and central nucleus of the amygdala have 
similar levels of B1a and B1b mRNA expression (Bischoff et al., 1999), they have different 
afferent and efferent projections (Zorrilla & Koob, 2013). The predominantly GABAergic 
central nucleus is the major output of the amygdala, and projects to the lateral hypothalamus 
and brainstem, among other areas. The predominately glutamatergic BLA feeds forward to 
the central nucleus and is reciprocally connected to the hippocampus. A majority of the 
amygdaloid projections to the ventral striatum, specifically the nucleus accumbens, originate 
in the BLA. Both the CeA and BLA are involved in reinforcement (Figure 2). Multiple 
studies have shown that reductions in dopaminergic excitation in the central amygdala 
reduce intake of reinforcers. Conversely, altering protein synthesis in the BLA prevents cue-
induced reinstatement and maintenance of conditioned place preference, while inactivation 
of the BLA abolishes cue-induced reinstatement (Duvarci & Pare, 2014; Zorrilla & Koob, 
2013). In light of the differing roles of the amygdala, Jacobson et al.’s (2006a) results could 
be interpreted as an indication that B1a and B1b receptors are working differently within the 
amygdala to regulate CTA. Loss of B1a receptors in the central amygdala could be reducing 
inhibition of excitatory output, resulting in a loss of control over reinforcer intake even 
following an aversive pairing (Figure 2A). Yet loss of postsynaptic B1b receptor inhibition 
in the BLA may contribute to the animal’s inability to learn that it is safe to consume the 
saccharin solution. Although ablation of the amygdala has been shown to abolish fear 
behavior (Zorrilla & Koob, 2013), loss of B1b receptor inhibition may lead to over-activity 
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of the amygdala by reduced control of excitatory output, thereby heightening fear levels and 
inhibiting the animal from sampling the saccharin solution (Figure 2B).
Short-term fear conditioning is also impaired in isoform knockout mice. Shaban et al. (2006) 
demonstrated that, when a 0.9 mA foot shock was given, B1a mice were unable to 
distinguish between two conditioned stimuli (CS). A CS− tone indicated safety from shock 
and a CS+ tone indicated shock, but B1a knockout mice showed the same amount of 
freezing during each tone without basal differences in locomotion or freezing behavior. 
However, the B1a mice had no differences in shock threshold compared to the wild type 
mice and learned the safety cue when a lower intensity shock (0.6 mA) was given. In 
contrast to B1a mice, B1b mice were completely unable to learn an association between the 
CS+ and foot shock, although their threshold for foot shock-induced movements or 
vocalization was not different than wild types (Table 1).
A longer contextual conditioned fear study was conducted in only B1a knockout and wild 
type mice (Cullen et al., 2014). Mice were given five 1-second shocks (0.8 mA) in context A 
and freezing behavior was assessed. Mice were then tested for freezing behavior in Context 
A, or a new Context B, 2 hours, 24 hours, or 5 days following the training session. B1a and 
wild type mice show similar levels of freezing in Context A during training and at all 
subsequent test points. In Context B, B1a knockout mice show low levels of freezing similar 
to that of wild type mice at the 2 hour post-training point. However, at 24 hours and 5 days 
post-training, the B1a knockout mice show increased freezing in Context B (Table 1). Taken 
with the findings of Jacobson et al. (2006a), the results of Vigot et al. (2006) may show that 
B1b mice are able to form implicit associations between a reflexive response to LiCl and an 
appetitive substance, but unable to form an overt cognitive association between a tone and a 
foot shock.
Cullen et al. (2014) interpret their results as showing that B1a knockout mice are initially 
able to consolidate the contextual memory, but are unable to maintain that memory over 
longer periods of time. These results are in opposition to the interpretation of Shaban et al. 
(2006), who attribute their short-term fear conditioning results to loss of glutamatergic-
related LTP in the amygdala of B1a knockout mice. Shaban et al. (2006) attribute their 
results to an inability of B1a knockout mice to make a tone-shock association. However data 
from Cullen et al. (2014) indicate that at 24-hours post-training, the B1a knockout mice are 
showing impaired contextual fear that is not present in the wild type animals. As Shaban et 
al. (2006) trained their animals in Context A, but tested them in Context B 24 hours later, 
this may indicate that freezing behavior in their mice may also be due to impaired contextual 
association. If re-tested in Context A 24-hours later, it is possible that the B1a mice would 
not have shown impaired tone-associations. Shaban et al. (2006) attribute behavioral 
findings in adult mice to neurological changes observed in adolescent brains. This 
explanation is broad, overlooks the developmental role of the isoforms, and neglects to 
examine the behavior of the B1b knockouts. An alternate interpretation for both Shaban et 
al. (2006) and Cullen et al. (2014) is that the B1a knockouts are showing greater stimulus 
generalization than the wild type mice. Shaban et al. (2006) suggest that stimulus 
generalization may be responsible for their results. Cullen et al. (2014) did not find 
immediate stimulus generalization at 2 hours and 24 hours post-training, although they also 
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used one training session. However, during the day 5 retention test, both genotypes show 
more freezing in Context B, but the B1a knockouts show significantly more than the wild 
types. This may indicate B1a knockouts are less susceptible to contextual-cue 
generalization, but that this generalization still develops more rapidly than in wild type mice.
Failure to learn the tone-shock association in the B1b knockouts may be due to the necessity 
of the lateral to central amygdala pathway in forming CS associations (Duvarci & Pare, 
2014). As the central amygdala is comprised of primarily GABAergic neurons, loss of 
postsynaptic B1b receptors to regulate the information being transmitted by the lateral 
amygdala may cause the loss of tone-shock association, thereby explaining the lack of 
freezing in response to the CS+ tone in the B1b knockout mice (Figure 3B). The 
mechanisms controlling non-discriminate B1a freezing may arise in the lateral amygdala. At 
a cellular level, tone-fear associations are more readily induced when GABAergic inhibition 
is reduced in the lateral amygdala (Duvarci & Pare, 2014). Loss of presynaptic B1a-
mediated inhibition in the lateral amygdala may indiscriminately increase tone-shock 
associations at the higher shock level in B1a knockout mice. As B1b receptors are still 
present in the downstream central amygdala of B1a knockouts, this increase in tone-shock 
association may lead to over-expression of freezing behavior (Figure 3A). A secondary 
explanation would be that tone discrimination and tone-shock pairing takes part in different 
areas of the brain. Although Shaban et al. (2006) observe differences in cellular function in 
the amygdala of B1a and B1b knockout mice, these differences do not provide causality. An 
amygdala-focused explanation diminishes the role of brain regions known to be associated 
with the amygdala. Reciprocal connections exist between areas of the amygdala and the 
prefrontal cortex, hippocampus, ventral striatum, and the brain stem, which play a major role 
in behavioral “fear output” (Duvarci & Pare, 2014; Zorrilla & Koob, 2013). Loss of tone 
discrimination within the B1a knockouts could result from aberrant connections between the 
auditory cortex, which initially processes the tone cue, and the amygdala. Behavior of the 
B1b mice may represent an atypical connection between the amygdala and the brainstem, 
wherein the amygdala fails to process the tone-shock association, thereby failing to produce 
a behavioral freezing response (Figure 3B). As discussed in section 4.1.1, these areas could 
be site-specifically targeted via receptor antagonism or isoform knock-in in the global 
isoform knockouts, or viral isoform knockdown in adult mice. These site-specific studies are 
necessary to investigate the way B1 isoforms are involved in circuitry of these behaviors.
Neither knockout genotype shows impairments in spatial association with a foot shock in the 
one-trial passive avoidance learning task. Jacobson et al. (2007a) placed animals in the light 
side of a light-dark box. Once animals traveled so far into the dark side, they were given one 
0.5 mA foot shock until they returned to the light side, for a maximum of 5 seconds. 
Twenty-four hours later, a retention test was given, where latency to enter the dark side of 
the box was tested. All genotypes showed an initial short latency to enter the dark box on the 
training trial and vocalized when receiving the shock. All genotypes learned the association 
of the dark side with the shock, showing a longer latency to enter the dark side on the 
retention trial (Table 1). Interestingly, the authors note that passive-avoidance learning is 
completely abolished in global B1 knockouts (see Schuler et al., 2001), indicating that a 
functional GABAB heterodimer is necessary for learning in this task, but learning is not 
specific to either of the receptor isoforms. Global knockout of the B2 subunit also abolishes 
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passive avoidance learning (Gassman et al., 2004). This indicates a necessity of GABABRs, 
but a nonspecific isoform role, in passive avoidance learning. This may indicate that 
GABAB autoreceptor function maintains this behavior, as both isoforms act as autoreceptors 
and presence of only one isoform is necessary to maintain behavior.
Most notably, all cognitive tasks were impaired apart from passive avoidance learning. This 
impairment was overwhelmingly a result of loss of the B1a receptor, except for spontaneous 
alteration and conditioned fear learning, which were respectively impaired and abolished in 
B1b mice (Jacobson et al., 2007a; Shaban et al., 2006). Many of the cognitive tasks used 
were relatively simple. Familiar object recognition, novel object recognition, and 
spontaneous alteration tasks simply consist of introducing the animal to the context and 
quantifying exploration over one session (Jacobson et al., 2007a; Vigot et al., 2006). Only 
CTA and Cullen et al.’s (2014) contextual fear task represent long-term behavioral assays 
with repeated testing sessions. Even within the short cognitive tasks reviewed within this 
section, no information was given on within session learning. As B1a animals failed to learn 
CTA, it is unclear how B1a is involved in the CTA extinction process, although it may be 
assumed that it plays a complementary role to B1b. Cullen et al. (2014) would suggest that 
B1a is necessary in maintaining memory by providing inhibitory input to neural structures 
involved in memory tasks. Although Cullen et al. (2014) examined long-term contextual 
memory, extinction should also be monitored in more traditional tone + shock associated 
tasks. A significant amount is known about how the amygdala and connected regions 
regulate consolidation, extinction, and reconsolidation of auditory-cued fear (Duvarci & 
Pare, 2014), which may allow for more complete interpretation of the roles of each receptor 
across a learning assay. Further, it would be of interest to examine the genotypes in long-
term retention tasks, such as the radial arm maze or Barnes maze, to observe if memory 
beyond 24 hours is affected in B1b mice as compared to wild type, or if there are 
impairments in short-term memory load. As B1b knockout mice show increased levels of 
immature, proliferating, and newly matured cells in the hippocampus compared to wild type 
mice (O’Leary et al., 2014), it is important to test B1b knockout mice in long-term cognitive 
tasks to observe if their performance is similar or enhanced compared to wild type animals.
4.2 Stress, Depression, and Anxiety
Tables 2–4 detail the role of B1 isoforms on tests of unconditioned anxiety (Jacobson et al., 
2007b) and anxiety following stress (O’Leary et al., 2014). O’Leary and colleagues 
employed two different forms of stress. The first was social stress, in which adult animals 
underwent 10 consecutive days of social defeat. The second was maternal separation with 
unpredictable stress (MSUS), in which dams were separated from their pups by a Plexiglas 
wall in the cage for 3 hours a day from PNDs 1–14. Separation happened at different times 
each day during the light cycle or early dark cycle. During separation the dam was stressed 
by 6 minutes of a forced swim task or 20 minutes of plastic tube restraint stress. Non-
stressed pups and dams were left undisturbed in their cages during the stress sessions. At 
weaning on PND21, the pups were group housed with pups from other litters to avoid 
maternal litter effects and behaviors were tested in adulthood. O’Leary et al. (2014) chose 
the MSUS model to attempt to invoke depressive and anxiogenic phenotypes in adult mice, 
which they note is hard to achieve in mice following stress paradigms, and that much of 
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their own work using this model has been done in rats. Previous studies have shown sex and 
genotype-specific effects of MSUS in B6 mice (Kundakovic et al., 2013; Weiss et al., 2011), 
which will be discussed alongside the results of O’Leary et al. (2014). The exact MSUS 
paradigm used by O’Leary et al. (2014) has not been characterized in BALB/C mice, which 
are the background strain of the isoform knockouts. This makes it difficult to compare 
results of their studies to the previous literature. Following MSUS, all animals underwent 
the same battery of tests in the following order: ultrasonic vocalizations, stress-induced 
hypothermia, open field locomotor test, tail suspension test, elevated plus maze, saccharin 
preference (females only), female urine sniffing test (males only), and the forced swim test. 
Apart from ultrasonic vocalizations, all behaviors were conducted in adulthood and were 
separated by a one-week period.
4.2.1 Null Results—Isoform knockout confers no effects on a variety of anxiety assays, 
including stress-induced hyperthermia with or without the presence of a previous stressor, 
the staircase test, the marble burying test, and the elevated plus maze with or without a 
previous stressor (Jacobson et al., 2007b; O’Leary et al., 2014) (Table 2). These tasks 
represent a range of anxiety behaviors. Stress-induced hypothermia is independent of 
locomotion, whereas the staircase test characterizes locomotor versus anxiolytic responses. 
Increased locomotion can be characterized in the elevated plus maze by observing number 
of open arm entries, but passive avoidance can also be observed in a mouse that enters a 
dark arm and remains there. Finally, marble burying acts as a quantifier of active anxiety 
behavior by observing defensive burying response. Interestingly, global B1 knockouts 
display less investigative behavior and more freezing in the staircase test (Mombereau et al, 
2004). As O’Leary et al. (2014) show no effects of individual isoform knockouts in the 
staircase task (Table 2), this indicates a necessary, but non-specific role of GABABR 
inhibition in regulating behavior in that task. O’Leary et al. (2014) found no differences 
between the controls and MSUS wild type animals in the elevated plus maze (Table 2), 
although using the same MSUS paradigm Weiss et al. (2011) found that stress reduced 
anxiety in males in females in the elevated plus maze. This may be due to O’Leary et al.’s 
(2014) controls being BALB/C mice, whereas Weiss et al. (2011) used B6 mice. Differences 
in behavior between these strains have been observed following maternal stress 
(Kundakovic et al., 2013). Lack of MSUS effects on anxiety behavior in the elevated plus 
maze may also be indicative of the sensitive nature of MSUS paradigms in mice (O’Leary et 
al., 2014). Alternative stress paradigms may be more appropriate for inducing behavior in 
BALB/C mice.
4.2.2. Non-Stress-Dependent Results—A few behavioral tasks exhibited non-stress-
dependent results. These included activity in the light/dark box, elevated zero maze, 
maternal care during MSUS, and the tail suspension test following MSUS (Table 3). Wang 
et al. (2011) have previously shown that maternal separation without stress does not alter 
activity of BALB/C mice in the light/dark box, indicating that only an isoform- and/or sex-
dependent result would likely be present in this task. Both the light/dark box and elevated 
zero maze compare the amount of time spent in the light versus dark areas of the apparatus 
to assess levels of anxiety. Basal anxiety differences were relegated to females, although 
anxiety levels were bidirectional in the female B1b knockouts, which showed reduced 
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anxiety in the light/dark box but increased anxiety in the elevated zero maze without being 
subjected to a previous stressor (Table 3). The bidirectional nature of results in the females 
is unexpected, as these two tasks are considered to test similar behavioral constructs aimed 
at the internal conflict of exploring a novel environment versus escaping an open area 
(Razafsha et al., 2013). Male B1b mice made fewer transitions between the light and dark 
compartments, but unlike the female B1b knockouts, there was no change in total time spent 
in the light side (Table 3). This indicates that male B1b mice may show reduced passive 
anxiety; each time they enter the light side of the box they spent more time in it (Jacobson et 
al., 2007b).
In the elevated zero maze, mice were initially placed into a dark quadrant of the maze. Male 
B1a and B1b isoform knockouts showed no alterations in anxiety, but this may have been 
due to high basal levels of anxiety in the wild type males. Female B1b mice showed an 
increased latency to enter a light quadrant and spent significantly less time in the light 
quadrants and made significantly less transitions between quadrants (Jacobson et al., 2007b) 
(Table 3). However, non-stressed female B1b knockouts show increased open field 
locomotion (O’Leary et al., 2014) (see Table 4). Results of the light/dark box and elevated 
zero maze interpreted with high basal activity in mind may indicate that female B1b mice 
actually show an increase in anxiety in both tasks, demonstrated by the latency times to 
enter the dark side of the light/dark box and a light quadrant of the zero maze. Such an 
interpretation removes the conflict of results in these similar tasks. Given their increased 
basal locomotor levels in the open field, it would be expected that female B1b animals 
would show a reduced latency in both tasks. Exploratory behavior inhibition and freezing 
when introduced into a new environment are often used to quantify anxiety (Palanza, 2001), 
and both of these behaviors appear to be occurring in female B1b mice during the light/dark 
box and zero maze assay, indicating that presence of B1b in females is protective in these 
two assays. Although latency to move was not measured, increases in total immobility are 
also seen during the forced swim task for all female B1b knockouts, possibly indicating an 
anxious response (O’Leary et al., 2014) (see Table 4). However, there are no effects of 
female B1b knockout on immobility in the tail suspension test (O’Leary et al., 2014), 
potentially suggesting that these two tasks designed to measure behavioral “despair” are 
intrinsically different than simple anxiety tasks, as they take place in an inescapable 
situation (Razafsha et al., 2013). Unfortunately, other tasks by Jacobson et al., (2007b) did 
not include latencies in their analyses. Therefore, we are unable to speak to whether female 
B1b animals show this exploratory and freezing inhibition in other anxiety or non-anxiety 
tasks. Freezing activity could easily be looked at in the elevated plus maze, Barnes maze, 
and in the fear tasks described in section 4.1, which did not use female mice. Further, 
freezing time following placement in the apparatus could be measured in all of these tasks 
by a trained observer or photobeam locomotor activity apparatuses. Looking at various 
specific behaviors within all of these tasks, including latency to transition, transitions made, 
total time moving, etc. is important in parsing out the known sex differences that are part of 
anxiety behavior. It is currently unknown what specific parameters of anxiety that sex 
affects, primarily because of the lack of preclinical research done in females. Organizational 
and activational effects of steroid hormones are often implicated in the different prevalence 
and expression of depressive and anxiety behaviors across males and females, and many 
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stress paradigms that induce depressive or anxiogenic phenotypes in males are unreliable in 
females (Palanza, 2001). Although it is commendable that Jacobson et al. (2007b) and 
O’Leary et al. (2014) included both male and female isoform knockouts, it difficult to begin 
to interpret sex-dependent isoform differences in these tasks because basic sex-dependent 
differences have not been fully identified.
Maternal care and the tail suspension test, which were done during or after MSUS, did not 
show stress-dependent effects on behavior, although some isoform- and sex-specific effects 
existed. Dams of B1a knockout pups showed higher maternal care on PND7 regardless of 
whether pups and dams endured MSUS (O’Leary et al., 2014) (Table 3). However, this did 
not confer a protective factor against stress effects on the pups (see Table 4). The tail 
suspension test, along with the forced swim task (see Table 4), measure learned helplessness 
as the amount of time spent immobile during the task. Learned helplessness, otherwise 
termed “despair,” is considered to be a hallmark of depressive symptomology. Two 
criticisms of these assays are that they are only acute stressors versus the pervasive, long-
term stressors seen in human depression, and that the behavior being modeled is not specific 
to depression; it may also be an expression of anxiety (Razafsha et al., 2013). In the tail 
suspension test, loss of B1a increased “despair” in male and female B1a mice, regardless of 
stress status. However, loss of B1b in male mice decreased “despair” regardless of stress 
status (O’Leary et al., 2014) (Table 3). Therefore, the isoforms appear to confer a 
bidirectional effect on behavioral despair in male mice only. The authors caution that 
decreased immobility in the male B1b knockouts may be due to increased activity seen in 
the open field. However, non-stressed female B1b knockouts also show this increased open 
field activity, although they do not display decreased immobility like the male mice do. 
Further, the same alterations in despair activity are not seen in the forced swim test (see 
Table 4), although the forced swim test is often used interchangeably with the tail 
suspension test to measure despair. These results may suggest that despair measures in the 
isoform knockouts under these paradigms are unreliable, and results of both the tail 
suspension test and forced swim test should be interpreted with caution for how isoform 
expression affects behavioral despair. Part of the unreliability in the current study may be 
due to order effects; the tail suspension test was always the third assay run, whereas the 
forced swim test was always the sixth assay run. By the time of the sixth behavioral test, the 
B1a knockouts may have lost their susceptibility for increased immobility that was seen in 
the tail suspension test. Although counterbalancing the order of tests may get around order 
effects, it may blunt true isoform differences in initial stress-susceptibility during the final 
tasks in a set of six behavioral assays. Order effects have previously been shown by 
Hohmann et al. (2013) using a modified version of maternal separation from PND2–7 in 
BALB/C mice, which includes stressing the pups, but not the dam. The authors 
demonstrated that increases in aggression seen in the stressed pups is present when the 
resident/intruder task is run first, but it is not present when following an open field task. The 
strongest way to determine if there are isoform-specific differences in initial stress-
susceptibility would be to run task-naïve animals through each behavioral assay. Following 
this initial assessment of each task, the animals could be run through batteries of other tests 
to see if initial stress-susceptibility is diminished over exposure to multiple behavioral tasks.
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4.2.3 Stress-Dependent Results—Some behavioral assays used by O’Leary et al. 
(2014) do appear to show stress-dependent results. Apart from the ultrasonic vocalizations 
before weaning and the open field locomotion, these tasks are considered to model different 
aspects of depressive phenotypes. Although discussed as a measure of anxiety, O’Leary et 
al. (2014) did not consider time spent in the middle of the field during their open field test, 
thereby characterizing it only as a measure of locomotor activity. As previously mentioned, 
the forced swim test, along with the tail suspension test, is widely used to characterize 
behavioral “despair” by looking at time spent immobile while placed in water. However, this 
task also models aspects reported by those suffering from anxiety, including a focus on harm 
and threats. Social interaction, saccharin preference, and urine sniffing are considered to 
model anhedonia that is often seen in depressive phenotypes. These tests are not considered 
to be “inescapable,” and therefore do not model “despair.” Rather, the animal is given a 
choice between investigating something that is typically thought of as preferable, or taking 
no action. Loss of preference for social interaction, a sweet reinforcer, or female urine 
sniffing for male mice is considered to model loss of pleasure that characterizes anhedonia 
(Razafsha et al., 2013).
How isoform knockout affects behavioral “despair” is currently unclear. Considering only 
the forced swim test, it would appear that B1a and B1b isoform knockout confers a 
protective factor against despair in all animals apart from the stressed female B1a and 
stressed male B1b knockouts (O’Leary et al., 2014) (Table 4). However, as discussed in the 
previous section, results of the forced swim test are hard to interpret for multiple reasons. 
Firstly, other behavioral assays run by O’Leary et al. (2014) do not fully support this 
interpretation. Results of the tail suspension test suggest that all B1a knockouts, regardless 
of stress- or sex-status, should show increased immobility whereas only male B1b knockouts 
should show decreased immobility in the forced swim test because the forced swim test and 
tail suspension test are believed to measure the same phenotype. O’Leary et al. (2014), 
interpret results of the tail suspension test by citing that all male B1b knockout mice show 
increased open field activity. However, decreased activity in the B1a knockouts and wild 
type mice compared to B1b knockouts might also be reflected in the forced swim task if it is 
relevant to the tail suspension task. It is important to keep in mind that the forced swim and 
tail suspension tests are not interchangeable. There is no change of hypothermia in the tail 
suspension test, and animals resume normal activity immediately following the assay, 
suggesting that tail suspension is less stressful or invasive than forced swim (Castagné et al., 
2011). Secondly, order effects have been shown when multiple behavioral tasks are run in 
succession following maternal separation (Hohmann et al., 2013). Therefore, results of the 
forced swim test could be confounded, as the forced swim test was always run last by 
O’Leary et al. (2014). Thirdly, whether maternal stress alone causes increased immobility 
during forced swim test is debatable (Mehta & Schmauss, 2011; Wang et al., 2011). Finally, 
Mombereau et al. (2005) have shown that loss of global B1 and B2 receptor expression 
leads to decreased activity in the forced swim task, therefore loss of activity may be due to 
loss of B2 receptors that colocalize with B1a and B1b subunits. The conclusion that B1b 
presence is protective against despair in females, whereas B1a presence is protective against 
despair in males may not be fully supported.
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The effects of stress and isoform knockout on anhedonic behavior are also unclear. O’Leary 
et al. (2014) generally suggest that their results show that presence of B1a is protective 
against a depressive phenotype, and B1b leads to susceptibility for a depressive phenotype. 
However, out of the 15 tasks characterized by Jacobson et al. (2007b) and O’Leary et al. 
(2014), only six behaviors show a “protective” effect of the loss of B1b irrespective of stress 
status. One of these tasks is simply increased open field activity (Table 4). Increased activity 
directly confounds interpretation of the tail suspension test, which is another of the six tasks 
used to identify a “protective” factor. The remaining four tasks are those that characterize 
anhedonia. Following social defeat, wild type mice showed reduced social interaction 
compared to their control counterparts, which has been previously demonstrated in BALB/C 
mice (Savignac et al., 2011). B1b knockout mice showed the same pattern of reduced social 
interaction, although non-stressed B1b knockouts showed significantly less interaction than 
non-stressed wild type mice. Stressed B1b knockout mice did not show different levels of 
interaction than their non-stressed counterparts. Non-stressed B1b knockouts were also not 
different from non-stressed wild type mice (Table 4). Saccharin preference following social 
defeat was decreased in B1a knockouts. This same reduction was seen in females B1a 
knockouts exposed to MSUS compared to wild type animals exposed to MSUS (Table 4). 
Males were not tested for saccharin preference following MSUS (O’Leary et al., 2014). 
Interestingly, Kundakovic et al. (2013) showed that their version of MSUS increased 
saccharin preference in female BALB/C mice, but this increase is not seen in the control 
mice exposed to MSUS by O’Leary et al. (2014), suggesting that this behavior may be very 
sensitive to slight differences in maternal stress paradigms. In male wild type mice, MSUS 
equalized preference for water versus female urine. Male B1a knockouts did not show a 
preference for female urine regardless of stress condition, whereas male B1b knockouts 
showed a preference for female urine regardless of stress condition, suggesting that their 
preference is not susceptible to stress-status (O’Leary et al., 2014) (Table 4).
These should be interpreted with caution considering the phenotypes produced by MSUS 
that have been previously demonstrated (Kundakovic et al., 2013; Weiss et al. 2011). 
O’Leary et al. (2014) found no differences in open field distance travelled, immobility time 
in the forced swim test, and saccharin preference between male and female control and 
MSUS-exposed wild type mice (Table 4). A lack of difference in open field distance 
travelled and immobility during the forced swim test following simple maternal separation 
in BALB/C males is supported by Wang et al. (2011). However, Mehta and Schmauss 
(2011) have shown that simple maternal separation using the same parameters as Wang et al. 
(2011) does cause increased immobility in male BALB/C mice during the forced swim task. 
Further, Kundakovic et al. (2013) have demonstrated that sucrose preference is increased in 
BALB/C males but decreased in females following maternal separation and pup stress. It is 
important to keep these results in mind, as these behaviors have not been well-investigated 
in BALB/C mice following MSUS. As previously mentioned, very little is known about 
what sex-status confers on anxiety and depressive phenotype susceptibility. Further, in 
regards to maternal stress models, many of these models are poorly characterized and very 
little is known about how the model used by O’Leary et al. (2014) affects anxiety and 
depressive phenotypes in different breeds of male and female mice. Although O’Leary et al. 
ran a large set of tasks using appropriate stressed and non-stressed wild type controls, these 
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tasks have been previously shown to be susceptible to order effects. As previously 
discussed, a better design would be to run these studies in sets of behaviorally naïve stressed 
and non-stressed males and females so that effects of stress-status and B1 isoforms can be 
better understood.
4.2.4 Neurobiological markers—The role of stress and genotype on corticosterone 
levels in isoform knockouts has also been investigated. O’Leary et al. (2014) took plasma 
corticosterone levels from stressed and non-stressed isoform knockouts and wild type mice 
30 minutes after the forced swim test within a four-hour period. All male B1b animals 
showed elevated corticosterone levels, whereas all B1a male knockouts showed reduced 
corticosterone levels, regardless of stress, compared to wild type mice. There were no stress 
or isoform effects on corticosterone levels in the female mice. Jacobson et al. (2007b) found 
no effect of genotype on corticosterone or adrenocorticotropic hormone levels, which they 
only assessed in experimentally naïve males during a one-hour period. This suggests that 
markers of HPA-axis activation are increased in response to the behavioral assays in the B1b 
knockout males, but reduced in B1a knockout males, regardless of stress condition. 
Activation of the HPA-axis in B1b male mice may contribute to their decreased anxiety 
profile in many of the behavioral tasks used. However, female B1b knockouts show no 
differences in corticosterone levels, although they do show a decreased anxiety profile 
similar to the males (Table 2, 3). This may indicate that males are more susceptible to the 
stress of behavioral tasks, or that other parameters apart from forced swim test-induced 
stress are influencing male isoform knockout corticosterone levels. Alterations in 
corticosterone levels to stress are highly susceptible to the duration and type of stress used, 
especially when considering maternal stress, as well as other factors, such as housing 
conditions, time of corticosterone testing, and other behavioral manipulations (Nishi et al., 
2013).
In adulthood, following MSUS, female stressed and non-stressed isoform knockouts were 
subjected to 2 hours of restraint stress and c-Fos levels were subsequently determined across 
different brain regions. O’Leary et al. (2014) demonstrated an increase in c-Fos in all B1b 
knockout mice in the dorsal and ventral dentate gyrus, the CA3 of the hippocampus, the 
paraventricular nucleus, and the dorsal raphe nucleus compared to wild type and B1a 
knockouts. Increased neuronal activation in the nucleus accumbens of B1b mice was 
dependent on the presence of stress. Stress also reduced c-Fos in the wild type dorsal dentate 
gyrus compared to their non-stressed counterparts. Non-stressed B1a knockout mice showed 
reduced c-Fos compared to wild type in the CA3 and the VTA. There were no differences in 
regions of the cortex or amygdala. The c-Fos results suggest that the genotypes show 
complex patterns of neuronal activation. Most importantly, the B1b knockouts show 
increased neuronal activation in areas of the hippocampus regardless of stress status, 
indicating that the hippocampal activation of B1b knockouts is aberrant compared to B1a 
knockouts and wild type mice regardless of stress condition.
Although c-Fos data was collected in females and the behavioral tasks detailed in Table 1 
were completed only using males, it is important to point out that B1a knockouts were 
impaired in familiar and novel object recognition, which are hippocampal-based tasks. 
However, c-Fos differences between the B1a knockouts and wild type were only seen in the 
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CA3 region, where non-stressed B1a knockout females showed reduced activation compared 
to wild type. The CA3 region is proposed to be important in integrating information relevant 
to memory encoding received directly from the entorhinal cortex and indirectly from the 
amygdala and cortex via the perforant path through the dentate gyrus (Palmer & Good, 
2011). Therefore, reductions in c-Fos in this area may be related to the decreased 
performance in memory-based tasks in the B1a knockout mice (Table 1). As previously 
mentioned, B1b knockout mice show increased c-Fos expression but not heightened 
performance in the short-term memory tasks, suggesting that there may not be a direct 
relationship between c-Fos expression and memory performance.
In the hippocampus, non-stressed B1b knockouts show increased total cell proliferation in 
the subgranular zone of the dentate gyrus and in the granular layer of the ventral dentate 
gyrus compared to wild type and B1a knockouts. Wild type and B1a knockouts showed no 
differences, and stress in the B1b animals normalized cell proliferation to levels of wild type 
animals. Cell survival was increased in the ventral subgranular zone of the dentate gyrus in 
the non-stressed B1b knockout animals. In the stressed B1b knockout animals, cell survival 
was increased in the subgranular and granular layer of the dentate gyrus, whereas wild type 
animals showed a reduction in these areas following stress. Non-stressed B1b knockout mice 
also showed an increase in immature cells in the dorsal hippocampus and dentate gyrus 
(O’Leary et al., 2014). These results suggest protective factors within the hippocampus of 
the B1b knockout mice, which fit well with proposed mechanisms of stress and 
neurodegeneration. Bao et al. (2008) put forth a model wherein the hippocampus regulates 
HPA-axis response that creates a spiral of stress-induced neurodegeneration. 
Neurodegeneration of the hippocampus, either preceding or following stress, reduces control 
of the HPA-axis, leading to increased stress and depressive responses, thereby leading to 
hippocampal neurodegeneration, and so on. As O’Leary et al. (2014) suggest, knockout of 
B1b receptors may lead to resilience in assays of anhedonia. Regardless of stress condition, 
B1b knockout mice show increase neuronal generation and activation within the 
hippocampus, potentially negating the effects of increased levels of HPA-axis activation, 
which may suggest an underlying mechanism of their behavioral resilience.
However, this explanation may be over-reaching. O’Leary et al. (2014) suggest that their 
results show that reductions in B1b receptors lead to stress resilience, whereas reductions in 
B1a receptors lead to stress susceptibility at a behavioral and neuronal level. Yet out of 
fifteen tasks looked at in the Jacobson et al. (2007b) and O’Leary et al. (2014) studies, only 
six assays show a “protective” effect of the loss of B1b regardless of stress status. One of 
these behaviors is simply increased activity in an open field, and another behavior, the tail 
suspension test, is directly confounded by increased activity in the B1b knockout mice. 
Further, much of the B1b knockout c-Fos data show increases in neuronal activity regardless 
of stress status (O’Leary et al., 2014). Increased levels of cell proliferation and immature 
cells do exist in the non-stressed B1b knockouts, but these levels are normalized following 
stress exposure and virtually unchanged in wild type and B1a knockouts following stress 
(O’Leary et al., 2014). If loss of B1b conferred a protective factor, instead of proliferation 
and immature neuron levels being normalized against wild type and B1a knockouts after 
stress, one may expect that wild type and B1a knockouts would also show decreases in cell 
proliferation and immature neuron levels following stress. It is also of interest to note that 
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the increases in immature neurons and cell proliferation in non-stressed animals do not 
appear to contribute to associative learning, as B1b animals are unable to extinguish CTA or 
learn a tone-shock association in conditioned fear (Jacobson et al., 2006a; Shaban et al., 
2006) (Table 1; discussed in section 4.1).
As shown in Table 5, antidepressant treatment upregulates mRNA expression of the B1a 
receptor. Baclofen binding was also increased in every case, except for in the hippocampus 
when fluoxetine was administered. Table 5 is important, as it indicates that antidepressant 
treatment upregulates B1a expression, and O’Leary et al. (2014) show that presence of only 
B1a increases c-Fos expression, number of immature cells, and immature cells in the 
hippocampus. Yet O’Leary et al. (2014) demonstrated an increase in B1b expression in the 
hippocampus of a model of selectively bred helpless mice compared to their non-helpless 
counterparts (H/Rouen and NH/Rouen, respectively). However, the studies reviewed in 
Table 5 demonstrate that antidepressants work to increase B1a expression, not to decrease 
B1b expression (Sands et al., 2004, 2003; McCarson et al., 2006). From a treatment 
standpoint, it is especially important to explore whether animals that show increased 
depressive and anxiogenic symptomology would have increased B1b expression that is 
attenuated by antidepressants, or if antidepressants would increase expression of B1a to 
normalize the system. Further, as indicated by increases in baclofen binding, the expression 
ratio of B1a to B1b may not be as important to the behavioral outcomes as changes in 
functional binding that increase stability of the GABAergic inhibitory system. Therefore, 
levels of baclofen binding during baseline and following antidepressant treatment should be 
looked at in models like the H/Rouen and NH/Rouen mice, as well as animals exposed to 
MSUS and other stress paradigms, and animals exposed to behavioral tasks that characterize 
depression and anxiety.
5. Drugs of Abuse
5.1 Cocaine
Not surprisingly, the GABABR system has been linked to cocaine self-administration and 
reinforcement in pre-clinical models. The earliest study to show involvement of presynaptic 
GABABRs in cocaine-response was Shoji et al. (1997). Following chronic cocaine 
injections, regulation of GABA and glutamate release in the dorsolateral septal nucleus was 
interrupted due to diminished activity of presynaptic GABABRs. Shoji et al. (1997) also 
suggested that chronic cocaine administration would alter dopaminergic transmission in 
other nuclei, such as the VTA, for which the dorsolateral septal nucleus is a relay center 
between the VTA and the hippocampus. Recent studies have supported Shoji et al.’s (1997) 
assertion that presynaptic GABABRs are involved in dopaminergic output, primarily by 
working in tandem with other receptor systems. Williams et al. (2014) demonstrated that 
corticotrophin releasing factor receptor 2 (CRF-R2) mediates GABA release from 
GABAergic-VTA interneurons, thereby activating nearby presynaptic GABABRs located on 
glutamatergic neurons, causing a decrease in glutamate release. This glutamate release is 
necessary for excitatory VTA output via dopaminergic projections. In times of stress, 
activation of this CRF-R2/presynaptic GABABR response would be expected to decrease 
excitatory output from the VTA. However, during chronic cocaine self-administration and 
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extinction, CRF-R2s lose their response to pharmacological agonism while presynaptic 
GABABRs become tonically activated. Williams et al. (2014) suggest that this loss of 
presynaptic GABABR-mediated glutamate release following cocaine self-administration 
would lead to an increase of excitatory VTA dopaminergic output following stress, instead 
of a decrease. Indeed, animals with a loss of B1a receptors do appear to be more susceptible 
to stress (see Table 3 for review). The VTA also has higher levels of B1a mRNA expression 
compared to B1b and levels of B1a in other brain areas (Bischoff et al., 1999), which 
indicates a strong role of B1a in mediating VTA excitatory output.
This increase in GABAergic interneuron/presynaptic GABABR-mediated dopaminergic 
output has also been demonstrated in mice that were prenatally exposed to cocaine (Wang et 
al., 2013). Interestingly, Wang et al. (2013) also showed that prenatal cocaine caused a 25% 
increase in B1a surface protein expression in the striatum in adulthood, but that B1b and B2 
protein levels were not affected. Thus, prenatal cocaine exposure may interfere with the 
typical trajectory of B1 isoform expression during development, as it has been previously 
shown that the striatum expresses more B1b mRNA but similar levels of B1a and B1b 
protein in adulthood (Bischoff et al., 1999; Fritschy et al., 1999). Prenatal exposure to 
cocaine may cause a significant increase of B1a protein compared to B1b, although this 
cannot be concluded definitively based on Wang et al.’s (2013) findings. Some evidence of 
interference in B1 levels following drug use has also been seen in humans. Human cocaine 
addicts, as well as human alcoholics and alcohol-naïve alcohol preferring (P) rats, show 
post-mortem decreases in overall B1 mRNA levels (Enoch et al., 2012). Although the 
findings of Enoch et al. (2012) are not isoform specific, they are important to consider. 
Overall reductions in B1 mRNA would suggest that human cocaine addicts and alcoholics 
do not show increased B1a mRNA levels or increased B1b expression levels during 
adulthood that would be expected based upon animal research (Bischoff et al., 1999; 
Fritschy et al., 1999; Liang et al., 2000). This suggests that these two drugs of abuse may 
disrupt normal brain function by reducing B1a mRNA levels as well as the number of B1b/
post-synaptic GABABRs (see section 2.3). Loss of B1a mRNA in drug addicts may lead to 
disruption in maintenance of brain function via loss of protein-protein interactions and 
continued developmental maintenance. Loss of B1a/B2 and B1b/B2 receptor expression 
may lead to impaired association, contextual, and aversive memories (see Table 1). Loss of 
the ability to form or maintain contextual associations seen in B1b and B1a isoform 
knockouts, respectively (Cullen et al., 2014; Shaban et al., 2006) may indicate that those 
who continuously use drugs may begin to lose the association between drug abuse and 
aversive situations, whereas reductions in B1a/B2 surface expression may prevent the drug 
abuse/aversive situation association from forming during the first instances of drug use. As 
alcohol-naïve P-rats also show reductions in overall B1 mRNA expression, this may indicate 
that low B1 mRNA expression is an indicator of drug abuse susceptibility, and may 
contribute to drug use and abuse for the reasons mentioned above.
Postsynaptic GABABRs have also been implicated in cocaine-response. Hearing et al. 
(2013) demonstrated that Layer 5/6 glutamatergic neurons of the mPFC, involved in the 
behavioral response to cocaine, are inhibited by GABAB neurons. This inhibition is 
mediated primarily by postsynaptic Kir.3 channels and repeated cocaine administration 
suppresses inhibition of the glutamatergic neurons via this pathway. This increased 
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excitation is behaviorally related to enhanced cocaine-induced locomotor activity and 
reduced locomotor sensitization to cocaine across trials. Locomotor sensitization to cocaine 
can also be attenuated by pharmacologically targeting the GABABR (Lhuillier et al., 2007). 
The mechanism by which cocaine induces alterations in neuronal excitation is via a 
reduction of GIRK2/B1 surface trafficking to the dendritic spine, due to a reduction of 
phosphorylation of serine 783 (S783). S783 phosphorylation leads to surface expression of 
B2, which is necessary for surface expression of B1 (Hearing et al., 2013). Terunuma et al. 
(2014) have demonstrated that replacement of S783 with an alanine increases Kir3 channel 
activation, which leads to impaired contextual fear, familiar object recognition, and Barnes 
maze performance, which may not be specific to the GABABR system. Hearing et al. (2013) 
also demonstrated that Ser-9, which is associated with GIRK2 phosphorylation, does not 
change following cocaine treatment. Taken together, these results may again suggest that 
increased Kir3 activity outside of the GABABR system leads to alterations in cognitive 
processes and behavioral responses to drugs of abuse, and that this increased activity can be 
mitigated via increased activity of the postsynaptic GABABR system.
Interestingly, cocaine treatment does not appear to regulate LTP response. Although B1a 
appears to regulate LTP in the hippocampus and amygdala, which are associated with loss of 
novel object recognition and conditioned fear, respectively (Shaban et al., 2006; Vigot et al, 
2006), GABABRs may not be involved in cocaine-induced LTP. Huang et al. (2007) 
demonstrated that antagonizing GABABRs blocks induction of LTP in mPFC pyramidal 
neurons of saline-treated rats, but that it does not reduce the increased LTP seen in cocaine-
treated animals. Conversely, antagonism of the GABAA receptor system increased LTP in 
saline-treated animals to levels seen in cocaine-treated animals without further increasing 
LTP in rats that received cocaine. Increased LTP in cocaine-treated rats was blocked by 
agonism of the GABAA receptor system. Thus, alteration of GABA-mediated LTP by 
cocaine is regulated by the GABAA receptor system. This may suggest that the role of 
GABABRs in drug seeking, intake, and behavioral changes in response to drugs may lie 
outside of the realm of cellular “learning,” which is associated with presynaptic B1a 
receptors, and may instead lie with postsynaptic mechanisms.
Multiple experiments would be needed to investigate the role of pre- versus postsynaptic 
GABABR involvement in drug reinforcement. As knockout of B1a or B1b appears to show 
different behavioral profiles, it would be of interest to see whether these profiles are altered 
with drugs of abuse on board. Long-term abuse of drugs such as cocaine in humans often 
leads to cognitive deficits in areas such as attention, working memory, and response 
inhibition (Sofuoglu et al., 2013). Aspects of these deficits can be modeled in animals by 
using the behavioral assays detailed in Table 1, as well as the radial arm maze, serial 
reaction time task, and delayed discounting tasks. As loss of B1a impairs object recognition, 
memory maintenance, and contextual fear, it may be expected that having cocaine on board 
during these tasks would further reduce performance in B1a knockout mice, whereas B1b 
knockout mice may perform similar to control animals with cocaine on board. The isoforms 
could also be investigated in conditioned place preference, conditioned aversion, and drug 
administration assays to observe how they regulate different aspects of drug reinforcement 
and seeking, which is currently unknown. Finally, considering the possible developmental 
role of the isoforms in drug addiction, the isoforms could be conditionally knocked out at 
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different times throughout adolescence and adulthood to observe effects on drug seeking and 
intake at different time periods. Another method to investigate adolescent abuse time-course 
would be to expose wild type animals to cocaine starting a different age periods, then using 
in situ hybridization to quantify changes in isoform mRNA or DNA expression levels.
5.2 Ethanol
The GABABR system is well-known to be involved in ethanol consumption, reinforcement, 
and withdrawal (Agabio et al., 2012). Most work looking at presynaptic GABABR and 
ethanol-mediated inhibition has been carried out in the primarily glutamatergic BLA, which 
has a small but important population of GABAergic interneurons (Silberman et al., 2009). It 
has been suggested that presynaptic GABAB autoreceptors work to mediate ethanol’s 
enhancing inhibitory effect at classic local interneurons, while ethanol-enhanced inhibition 
in GABAergic lateral paracapsular interneurons is adrenoceptor-dependent (Silberman et al., 
2012, 2009, 2008; Zhu & Lovinger, 2006). Therefore, ethanol’s effects within the BLA are 
not specific to GABABRs. Further, as both B1 isoforms act as autoreceptors, these results do 
not indicate a GABABR isoform-specific role in ethanol-induced system inhibition. 
However, a postsynaptic GABABR mechanism mediated through Kir3 channels has been 
identified. Federici et al. (2009) demonstrated that ethanol application increases GABAB-, 
but not GABAA-, mediated IPSPs in postsynaptic dopaminergic neurons of the VTA and 
substantia nigra pars compacta. Simultaneous application of baclofen and ethanol 
demonstrated that outward K+ currents induced by baclofen were potentiated by alcohol, 
producing a stronger postsynaptic inhibition of dopaminergic neurons. This potentiation is 
of interest to drug abuse researchers, as baclofen has been repeatedly demonstrated to reduce 
ethanol intake in both clinical and pre-clinical models (see Agabio et al., 2012 for review). 
Whereas the data presented by Federici et al. would suggest that, if ethanol-induced 
GABABR-mediated postsynaptic depression of dopaminergic output within the ventral 
tegmental area is an underlying cause of ethanol reinforcement, then GABAB agonists such 
as baclofen would amplify this reinforcement instead of alleviating it. One explanation may 
be developmental. It is important to note that slices used by Federici et al. (2009) were taken 
during a wide range of the rat adolescent period (PND 14–35), during which GABABR 
surface expression levels are rapidly changing (Fritschy et al., 1999). Based on data 
discussed within this section and throughout the review, it is possible that adult slices would 
show decreased or even abolished postsynaptic GABABR/ethanol inhibition, and that 
instead postsynaptic inhibition may be regulated by the GABAAR. Secondarily, fully 
developed brains may not show the postsynaptic inhibitory effects of ethanol that are 
demonstrated in the developing brain. One theory may be that, in adolescence, heightened 
B1b/B2 receptor surface expression may augment responses to ethanol intake, and that this 
increase in postsynaptic GABABRs and ethanol sensitivity may lead to altered 
reinforcement of ethanol intake. In the developed brain, lower surface expression of B1b/B2 
receptors and/or altered sensitivity to alcohol may create a system where GABABR agonism 
works against ethanol, making it a valuable pharmacological treatment for alcohol use 
disorders. Behaviorally, this could be investigated by placing adolescent animals in an 
operant self-administration paradigm in which they receive ethanol. Following acquisition of 
response and relevant levels of intake, baclofen would be administered and ethanol intake 
would be monitored. An increase of responding for/intake of ethanol could be interpreted as 
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a synergistic effect of baclofen + ethanol inhibition of dopaminergic VTA neurons in 
adolescents. Due to the short period of adolescence, it may be more favorable to use a short-
term design that monitors intake but not perceived reinforcement. One such model is 
drinking-in-the-dark (DID), which leads to high ethanol intakes in a brief period of time that 
does not require training (Rhodes et al., 2005). As in the operant paradigm, baclofen could 
be administered on the final day of drinking and ethanol intake would be observed. A DID 
design would allow for monitoring over very brief periods of adolescence to observe 
whether there is a change in baclofen sensitivity that is associated with adolescent 
development.
Other studies have contradicted the findings of Federici et al. (2009). Theile et al. (2011) 
demonstrated that ethanol increases DA neuron firing in the VTA in more tightly regulated 
adolescent slices (PND 21–28), and that the effects of ethanol can be inhibited by both 
GABABRs and GABAARs. Xiao et al. (2009) have also demonstrated that ethanol increases 
DA neuron firing in the VTA of rat brain slices aged PND 22–32 by potentiating presynaptic 
glutamate release. Importantly, it has been demonstrated that ethanol self-administration 
during adolescence increases excitatory postsynaptic NMDA receptor levels in the VTA of 
adult rats (Stuber et al., 2008). These results highlight the necessity of considering 
developmental factors and using tightly controlled age groups in experiments.
As demonstrated in animals prenatally exposed to cocaine (Wang et al., 2013), presynaptic 
GABABRs may also play a critical role during adolescent ethanol exposure. Mishra and 
Chergui (2013) stimulated glutamatergic fibers of the nucleus accumbens core of adult and 
adolescent (PND22–30) mice and observed field EPSPs and population spikes. Ethanol 
reduced postsynaptic glutamate responses to a greater degree in adolescent slices. This 
reduction was blocked by antagonism of both GABAARs and GABABRs in adolescent 
slices. Due to the minimal postsynaptic depression in adult slices, GABA receptor 
antagonism in the presence of ethanol was not carried out in adult slices. However, agonism 
of the GABAARs and GABABRs alone caused a much more pronounced reduction in 
postsynaptic activity in adolescent compared to adult slices, whereas GABAAR antagonism 
alone caused a more pronounced increase in glutamatergic postsynaptic activity in adult 
slices, and GABABR antagonism alone had no effect. Mishra and Chergui (2013) suggest 
that their results show a presynaptic GABAergic mechanism of postsynaptic glutamatergic 
excitation. In adult mice, it appears that GABA is released and binds to GABAARs, causing 
inhibition of glutamatergic activity. However, in adolescent mice, GABA may be 
overflowing to presynaptic GABABRs, which also work to modulate glutamatergic activity. 
Although there is more B1b than B1a surface expression during the age at which Mishra and 
Chergui (2013) took their adolescent slices (Fritschy et al., 1999), there is no indication 
whether the nucleus accumbens of an adolescent mouse has a greater GABABR to 
GABAAR ratio than the adult mouse.
These results support well-established findings that the GABABR system is a target for 
alcohol use disorder intervention. Although the current research does not support a need for 
development of isoform-specific drugs, not enough investigation has been done in this area 
to be conclusive. As with the cocaine data, these results potentially implicate the GABABR 
system as an early marker of abuse liability as well as a potential treatment target for 
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adolescents involved in misuse and abuse of drugs. B1 isoforms could be investigated in 
multiple ways related to ethanol intake. These include how ethanol affects the memory 
impairments present in B1a knockout mice, how isoforms are involved ethanol seeking and 
reinforcement, and how the isoforms are involved in the developmental trajectory of ethanol 
intake and reinforcement. Studies could incorporate isoform knockouts to observe direct 
influence of overall or site-specific knockout on future ethanol intake, or they may expose 
the animal to ethanol and behavioral tasks then run in situ hybridization to characterize how 
ethanol alters baseline levels of isoform mRNA and DNA expression.
5.3 Isoform-Specific Pharmacological Interaction
Research investigating differential pharmacological profiles of each isoform is limited and 
does not support a role of differential action for treatments that target GABABRs. Many 
drugs that interact with GABABRs are positive allosteric modulators, which bind to the B2 
subunit of the receptor (Pin et al., 2004). As all functional receptors include this B2 subunit, 
it is unlikely that positive allosteric modulators themselves would have differing actions at 
B1a/B2 or B1b/B2 receptors. Further, auxiliary proteins, which interact with the GABABR 
complex, have not yet been shown to affect GABA affinity or drug efficacy at native 
receptors. Complement control protein 1, which is present only on B1a receptors, is able to 
bind to the matrix protein fibulin-2. Fibulin-2 can bind to extracellular ligands and calcium, 
but binding of fibulin-2 to the B1a receptor is not specific to the presence of complement 
control protein 1, indicating a non-specific effect (Hannan et al., 2012; Blein et al., 2004). 
Rajalu et al. (2015) demonstrated that different K+ channel tetramerization-domains, which 
bind to postsynaptic B1b/B2 receptors and the associated G-protein, do not alter basal 
GABA affinity or GABA affinity of native cells in the presence of the positive allosteric 
modulator GS39783.
Cell-type and receptor-location effects of GABABR agonists have been shown. Yu et al. 
(1999) determined that the GABABR agonist CGP44533 is less efficacious and potent at 
GABAergic interneurons compared to glutamatergic neurons. CGP44533 also works less 
potently and efficaciously at autoreceptors than at heteroreceptors. However, as both 
isoforms act as autoreceptors, this does not speak to a diverging pharmacological profile. 
Although each isoform produces different behavioral profiles, R-baclofen similarly mediates 
locomotor and endurance behaviors as well as temperature changes in both isoform 
knockouts (Jacobson et al., 2006b). These results are not surprising, as many studies have 
reported that each isoform shows similar levels of agonist and antagonist potency, as well as 
the same rank-order of potency (Bräuner-Osborne & Krogsgaard-Larsen, 1999; Green et al, 
2000; Malitschek et al. 1998). However, Malitschek et al. (1998) demonstrated that R-
baclofen is much more potent in the adult brain. Compared to PND 4, mid-range baclofen 
doses bind 40% more to B1a and B1b receptors in the adult brain. Although potency 
normalizes across adolescence, at PND 28 there are still lower levels of baclofen binding 
compared to the adult brain (Malitschek et al., 1998). Once again, these results suggest that 
adolescents and adults show a different GABABR pharmacological profile that may be of 
important consideration for the etiology of disease. Although current research does not 
suggest isoform-specific roles for pharmacological treatments that target GABABRs, it is 
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possible that use of Ca++ or K+ channel drugs may independently regulate behaviors that 
have been shown to be isoform specific.
6. Conclusions
In conclusion, the initial hypothesis of this review was confirmed. GABAB isoform 
knockout mice show a broad spectrum of isoform-specific behaviors. Global B1 and B2 
subunit knockout studies have indicated many deficits in animals that do not express 
GABABRs. At times these deficits are isoform specific, such as the role of B1a in 
hyperactivity, seizure activity, protection of depressive phenotypes, and memory 
maintenance (Cullen et al., 2014; Jacobson et al., 2007a; O’Leary et al., 2014; Vienne et al., 
2010), whereas B1b is involved in susceptibility to depression-like phenotypes and impaired 
memory formation (Cullen et al., 2014; O’Leary et al., 2014; Shaban et al., 2006). In other 
behavioral assays, such as seizure activity, tests of anxiety, and impaired passive avoidance 
learning, the presence of functional GABABRs containing either B1 isoform rescues the 
aberrant behavior seen in B1 and B2 subunit knockout mice (Gassman et al., 2004; Jacobson 
et al., 2007a; 2007b; Mombereau et al., 2005, 2004; O’Leary et al., 2014; Schuler et al., 
2001; Vienne et al., 2010). Although pre- and postsynaptic GABABRs may play specific 
roles in controlling differing aspects of addictive drives and behavior, the necessity of 
development of isoform-specific drugs to treat drug use disorders is not currently supported. 
However, it appears that GABABRs may be involved in development of drug-use disorders 
and the isoforms may act as biomarkers for such disorders. Isoform-specific drug 
development may be useful for cognitive disorders, such as short-term memory loss or 
Alzheimer’s disease. Treatments that target B1a may aid in memory maintenance, whereas 
treatments that target B1b may aid in initial memory consolidation. Although more research 
needs to be done, it is possible that development of a B1a-specific drug may work well as an 
anti-depressant treatment, as presence of B1a may be protective against symptoms of 
anhedonia following stress. As isoforms play a role in development of the central nervous 
system, their roles in behavior may develop over time and developmental considerations are 
important when considering etiology and treatment of behaviors and disease.
Although the studies reviewed herein confirm an isoform-specific role in behavior, there are 
a lot more studies that need to be done. A current issue is the lack of behavioral tests done in 
female animal models. Section 4.2 discusses how sex differences are known to be involved 
in phenotypes of depression and anxiety as related to isoform expression. However, few 
behaviors are well-characterized in males versus females, and this work must be done as 
well as including females in all future experiments. It is possible that there are sex-specific 
isoform roles in cognitive tasks, development of drug-use disorders, and response to 
pharmacological treatment. Further, the isoforms may play different roles in the course of 
basic male and female development, which need to be investigated to better understand how 
the B1 isoforms may be playing a sex-specific role in adult behavior.
The studies discussed within this review also implicate different brain areas for each 
behavioral deficit. However, all of these studies used global knockouts, making it impossible 
to directly implicate specific brain regions in all of the current behavior. In global isoform 
knockouts, brain-region specificity could be investigated by site-specifically antagonizing 
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receptor systems that are over-excited by loss of each isoform, such as the glutamatergic 
system. Conversely, the isoforms could be knocked-in to the region of interest. Both of these 
designs would “normalize” the over-excitation caused by isoform loss. However, the best 
study design would be to use a site-specific viral isoform knockdown in adulthood. Such a 
design would bypass the concern of compensation in the isoform knockouts, thereby giving 
a better indicator of how the isoform is site-specifically involved in behavior.
Finally, the GABABR system is known to be strongly involved in drug abuse. However, no 
studies have been carried out to look at the role of isoform knockout in development or 
maintenance of drug addiction. As it appears that the isoforms may play a developmental 
role in addictive behavior, isoform knockouts could be used in studies that look at 
adolescent pre-exposure to drugs and how such pre-exposure may alter abuse liability in 
adulthood via free-choice drinking and operant drinking. Neurobiological studies could also 
be conducted to look at how isoforms and pre-exposure alters neurotransmitter signaling of 
dopamine, glutamate, and other systems of interest. Using viral knockdown of each isoform 
at specific time-points during adolescent drug-intake would give a clear idea of when 
isoforms are playing a role in drug susceptibility. How behavioral tasks alter baseline levels 
of isoform expression is also of importance, especially when considering drug treatment for 
such disorders. As discussed in section 4.2.4, antidepressant treatment alters isoform mRNA 
expression and baclofen bindings. However, how a battery of tasks that are thought to mimic 
depressive and anxiety-like phenotypes alters isoform expression is unknown, making it 
difficult to extrapolate how behavior, treatment, and isoform expression are inter-related. 
Looking at changes in mRNA and protein expression of each isoform using in situ 
hybridization following drug administration and treatment would also be informative. Basic 
in situ hybridization studies would allow for a basic understanding of how isoforms are 
expressed across the brain following behaviors of interest and drug treatment, allowing for 
better designed knockout studies and interpretation of behavioral data. Although the current 
research supports an isoform-specific role in behavior, the suggested studies would better 
inform how these isoforms are involved in sex- and isoform-specific behavior as well as 
trajectory of drug abuse.
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Highlights
• GABAB1a contributes to memory maintenance.
• GABAB1b contributes to initial memory formation.
• Excessive GABAB1b may contribute to behavioral aspects of anhedonic 
phenotypes.
• Excessive GABAB1a may prevent an anhedonic phenotype.
• Both isoforms may be involved in the developmental trajectory of disorders.
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Figure 1. 
Figure 1 details the hippocampal circuitry believed to be involved in memory maintenance. 
Panel A details typical function, in which a B1aRs and mGluRs are co-localized on the 
projection from the dentate gyrus and entorhinal cortex to the CA3 region of the 
hippocampus. Binding of GABA to the B1aR regulates glutamate release, thereby regulating 
LTP in the CA3. Panel B shows this same circuitry following loss of the B1aR on the 
afferent projections. Loss of presynaptic GABAergic control increases release of glutamate, 
resulting in unregulated LTP in the CA3 and loss of memory maintenance.
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Figure 2. 
Figure 2 details the circuitry of the central and basolateral amygdala regions (CeA and BLA, 
respectively) in conditioned taste aversion. Panel A shows the circuitry of a B1a knockout, 
where the B1aR on the glutamatergic projection from the BLA to the CeA is lost. This loss 
results in decreased presynaptic inhibitory regulation of the glutamatergic projection, 
leading to increased excitatory input to the CeA. This may contribute to loss of fear 
inhibition. Panel B shows the circuitry of the B1b knockout, where B1bRs located in the 
BLA, which regulate excitatory input to and from the hippocampus and to the ventral 
stiatum and CeA. This loss of postsynaptic inhibition leads to excessive excitatory output, 
contributing to loss of extinction.
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Figure 3. 
Figure 3 details the circuitry of the amygdala believed involved in conditioned fear 
response. Panel A shows the circuitry of B1a knockout mice. Loss of B1a presynaptic 
inhibition of the GABAergic projection from the auditory cortex to the lateral amygdala 
(LA) leads to loss of tone discrimination. This loss of discrimination is relayed to the central 
amygdala (CeA) and results in decreased inhibition of the brainstem, leading to increased 
freezing during the session. Panel B shows the circuitry of B1b knockout mice. Tone 
discrimination is relayed from the auditory cortex to the LA. However, loss of postsynaptic 
B1bRs in the CeA results in loss of tone information relay from the LA to CeA and results 
in increased CeA excitation. This increased excitatory input results in increased brainstem 
inhibition, which results in loss of freezing behavior in the B1b knockout mice.
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Table 1
Contributions of the GABABR isoforms to cognition1
Behavior Direction Knockout
Genotype
Publication
Familiar object recognition Impaired B1a Vigot et al., 2006; Jacobson et al., 2007a
Novel object recognition Impaired B1a Vigot et al., 2006; Jacobson et al., 2007a
Novel object recognition – consolidation No effect n/a Cullen et al., 2014*
Novel object recognition – maintenance Impaired B1a
Spontaneous alteration Impaired B1a, B1b Jacobson et al., 2007a
Conditioned taste aversion – learning Abolished B1a Jacobson et al., 2006a
Conditioned taste aversion – extinction Impaired B1b
Conditioned fear – learning Impaired, abolished B1a, B1b Shaban et al., 2006
Conditioned fear – same context No effect n/a Cullen et al., 2014*
Conditioned fear – different context Impaired B1a
Passive avoidance learning No effect n/a Jacobson et al., 2007a
1
“Direction” indicates in comparison to wild type mice.
Asterisk (*) indicates that Cullen et al., (2014) only used wild type and B1a knockout mice.
“n/a” refers to “not applicable” in cases where no significant results were reported.
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Table 2
Null Results2
Behavior Direction Knockout
Genotype
Publication
Stress-induced hypothermia No effect n/a Jacobson et al., 2007b
MSUS stress-induced hypothermia No effect n/a O’Leary et al., 2014
Staircase test No effect n/a Jacobson et al., 2007b
Marble burying No effect n/a
Elevated plus maze No effect n/a
MSUS elevated plus maze No effect n/a O’Leary et al., 2014
2
These behavioral tasks showed no effect of isoform on basal anxiety or anxiety measures following maternal separation unpredictable stress 
(MSUS).
“n/a” refers to “not applicable” in cases where no significant results were reported.
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Table 3
Non-Stress-Dependent Results3
Behavior Direction Knockout
Genotype
Publication
MSUS maternal care Increased All FB1a O’Leary et al., 2014
Light/dark Box Reduced anxiety* FB1b Jacobson et al., 2007b
Elevated zero maze Increased anxiety FB1a, FB1b Jacobson et al, 2007b
MSUS tail suspension test Increased immobility All FB1a, All MB1a O’Leary et al., 2014
decreased immobility All MB1b
3All “directions” are compared to wild type mice in the same task unless marked by an asterisk (*), thereby indicating the direction is compared to 
the other isoform knockout.
“MSUS” in the behavior column indicates that the task took place following unpredictable maternal stress. In the genotype column, “FBla” and 
“FB1b” indicate female mice. “MB1a” and “MB1b” indicate male mice. “NMS” indicates no stress, and “MS” indicates maternal stress. “All” 
indicates a main effect of genotype – results were not specific to stress condition. O’Leary et al. 2014 tested MSUS saccharin preference only in 
female mice, and MSUS female urine sniffing only in male mice.
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Table 4
Stress-Dependent Results4
Behavior Direction Knockout
Genotype
Publication
Social interaction following social defeat Increased B1b O’Leary et al., 2014
Decreased B1a
Saccharin pref. following social defeat Reduced B1a
MSUS saccharin preference Reduced MS FB1a
MSUS female urine sniffing Increased MS MB1b
MSUS PND7 vocalizations Increased MS B1b
MSUS Open field locomotion Increased NMS FB1b, All MB1b
MSUS forced swim task Decreased immobility NMS FB1a, All FB1b, All MB1a, NMS MB1b
4All “directions” are compared to wild type mice in the same task unless marked by an asterisk (*), thereby indicating the direction is compared to 
the other isoform knockout.
“MSUS” in the behavior column indicates that the task took place following unpredictable maternal stress. In the genotype column, “FBla” and 
“FB1b” indicate female mice. “MB1a” and “MB1b” indicate male mice. “NMS” indicates no stress, and “MS” indicates maternal stress. “All” 
indicates a main effect of genotype – results were not specific to stress condition. O’Leary et al. 2014 tested MSUS saccharin preference only in 
female mice, and MSUS female urine sniffing only in male mice.
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Table 5
Anti-depressants and isoform mRNA expression5
Drug Region Direction Isoform Publication
Tranylcypromine (10 mg/kg) Hippocampus Increased B1a, B2 Sands et al., 2003
Phenelzine (10 mg/kg) Hippocampus Increased B1a
Fluoxetine (5 mg/kg) Hippocampus Increased B1a
Fluoxetine (5 mg/kg) Lumbar spinal cord Increased; Decreased B1a; B2 McCarson et al., 2006
Desipramine (15 mg/kg) Hippocampus Increased B1a Sands et al., 2003
Desipramine (15 mg/kg) Spinal cord dorsal horn Increased B1a, B2 Sands et al., 2004
Amitriptyline (10 mg/kg) Lumbar spinal cord Increased; Decreased B1a, B1b; B2 McCarson et al., 2006
5
Table 5 indicates the effects of different antidepressants on GABABR subunit and isoform expression. All results were gathered using in situ 
hybridization, and direction indicates a comparison to baseline. Tranylcypromine and phenelzine are MAOIs, fluoxetine is an SSRI, and 
desipramine and amitriptyline are tricyclics.
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